Programme

Preliminary programme

TUESDAY, JULY 10, 2018

07:30 – 18:00 Registration
Room:
Quays Bar

09:00 – 10:30 IHN General Assembly
Room: 
Pier Eight Room

(10:30 – 11:00) Coffee Break

11:00 – 13:00 Opening Session
Room: 
Quays theatre
Chairpersons:
 Wood E. (Australia) and Wiersum‑Osselton J.C. (The Netherlands)

(11:00 – 11:05) Welcome and Opening.
(INV-01) Wood E., President IHN (Australia)

(11:05 – 11:30) TACO: A Call to Action.
(INV-02) Wiersum-Osselton J.C. (The Netherlands)

(11:30 – 12:00) Transfusion-related acute lung injury: An Update.
(INV-03) Vlaar A. (The Netherlands)

(12:00 – 12:30) Transfusion-associated dyspnea (TAD): “A ROSE”* by many other names.
(INV-04) Andrzejewski C. (USA)

(12.30 – 13.00) Discussion

(13:00 – 14:30) Lunch Break

14:30 – 17:00 Parallel Sessions

1)  Haemovigilance: Donors and Donor Attributes
Room: Quays theatre
Chairpersons: 
Escoval M.A. (Portugal) and Roberts D. (United Kingdom)

(14:30 – 15:00) Blood donor inter-donation interval.
(INV-05) Roberts D. (United Kingdom)

(15:00 – 15:30) The best blood donor and blood product for each patient: an evolving role for  haemovigilance?
(INV-06) Tiberghien P. (France)

(15:30 – 16:00) Tea Break

16:00 – 17:00 Short presentations from selected abstracts

(16:00 – 16:15) Small change, big impact: A review of reported plaster reactions and lessons learnt following the introduction of a new adhesive arm dressing for blood donors in 2017
(O-S1-1) Narayan S., Morris C., Senior P., Heal S., Cullen D., Anderson N. (United Kingdom)

(16:15 – 16:30) Adverse events on blood donors in Transfusion center General Hospital Celje from 2014 to 2017
(O-S1-2) Pajk J. (Slovenia)

(16:30 – 16:45) Risk factors for tiredness after blood donation
(O-S1-3) Morand C., Vermorel C., Rolland C., Legrand D., Couturier N., Tiberghien P., Bosson J.L. (France)

(16:45 – 17:00) Fatigue following whole blood donation: electronic survey in a cohort of young new and novice donors
(O-S1-4) Wiersum-Osselton J.C., van Dongen A., Marjit T., van den Brekel E., Hermans F., Romeijn B., Bokhorst A. (The Netherlands)

2) Haemovigilance: Recipients
Room: 
Pier Eight Room
Chairpersons: 
Field S. (Ireland) and Bisht A. (India)

(14:30 – 15:00) Platelet transfusions: Lessons from the PATCH study.
(INV-07) Cordonnier C. (France)

(15:00 – 15:30) Haemovigilance in paediatrics.
(INV-08) Stanworth S. (United Kingdom)

(15:30 – 16:00) Tea Break

16:00 – 17:00 Short presentations from selected abstracts

(16:00 – 16:20) Up-to-date competency assessments do not prevent transfusion with wrong components (WCT) following laboratory-related errors
(O-S2-1) Mistry H., Bolton-Maggs P., Rook R., Baker P. (United Kingdom)

(16:20 – 16:40) Towards characterization of acute pain transfusion reactions
(O-S2-2) PY J-Y., Boudjedir K., Cabezon B., Sandid I. (France)

(16:40 – 17:00) Near-misses in sample collection and in blood component transfusion. An incidence study using an electronic transfusion safety system
(O-S2-3) Bueno J.L., Álamo J.R. Berzal L., Alonso R., Gonzalez C.I., Cruz J.L., De la Puente C., Moran A., Asensio A., Nunez M.J., Cabrera J.R. (Spain)

17:00 – 18:00 Poster Session

18:00 – 19:00 Welcome Reception

19:00 – 21:30 Participant Dinner. Click here for more information

WEDNESDAY, JULY 11, 2018

08:00 – 16:30 Registration
Room:
Quays Bar

09:00 – 12:10 Parallel Sessions

3) Biovigilance
Room: Quays Theatre
Chairpersons: Bokhorst A. (The Netherlands) and Tiberghien P. (France)

(09:00 – 09:30) Biovigilance in the USA.
(INV-09) Anderson S. (USA)
(09:30 – 10:00) Biovigilance in India.
(INV-10) Bisht A. (India)

(10:00 – 10:30) Coffee Break

10:30 – 12:15 Short presentations from selected abstracts

(10:30 – 10:50) Comparing clinical use and transfusion reaction risks accros transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands
(O-S3-1) Saadah N.H., Schipperus M.R., Wiersum-Osselton J.C., van Kraaij M.G., Caram-Deelder C., van der Bom J.G. (The Netherlands)

(10:50 – 11:10) Robust inactivation of Yellow Fever Virus 17D vaccine strain can be achieved by photochemical treatment of platelet concentrates
(O-S3-2) Laughhunn A., Payrat J.M., Santa Maria F., Girard Y., Lanteri M., Bringmann P.(USA)

(11:10 – 11:30) PAS-E platelet additive solution haemovigilance report, residual risk and risk/benefit update
(O-S3-3) Sumian C., Tolksdorf F., Alvarez I. (Germany)

(11:30 – 11:50) Untargeted “label-free” proteomics study to understand platelet transfusion adverse reaction
(O-S3-4) Barlier C., Aloui C., Claverol S., Fagan J., Tavernier E., Guyotat D., Cognasse F., Garraud O., Laradi S. (France)

(11:50 – 12:10) Serious Transfusion Incident Reporting: a key activity of the Australian ‘Blood Matters’ blood management program
(O-S3-5) Akers C., Wood E., Davis K A., Bielby Linley., Glazebrook B., Beard P., Daly J. (Australia)

4) Haemovigilance around the world
Room: 
Pier Eight Room
Chairperson: Schipperus M. (The Netherlands) and Field S. (United Kingdom)

(09:00 – 09:30) Just in time blood delivery
(INV-11) Williams L.H. (USA)

09:30 – 10:00 Short presentation from selected abstracts

(09:30 – 09:45) Acute haemolytic transfusion reactions in Croatia – 10 years overview
(O-S4-1) Štimac R., Luki´c M., Vuk T., Lukic I. (Croatia)

(09:45 – 10:00) Hospital-based Haemovigilance Programme in a Quaternary Hospital in Hong Kong: A Decade of Experience
(O-S4-2) Leung R., Lam C., Lie A., Hwang G., Yan T. (China)

(10:00 – 10:30) Coffee Break

10:30 – 12:15 Short presentations from selected abstracts

(10:30 – 11:00) Haemovigilance in China.
(INV-12) Liu Z. (China)

(11:00 – 11:30) Haemovigilance in Taiwan
(INV-13) Lin D.T., Yun-Yuan C., Chen H.C., Wei S.T., Hou S.M. Chu F.Y. (Taiwan, Republic of China)

(11:30 – 11:45) Active Quarantine Haemovigilance programs multiply the adverse events rates.The HEMACUA project
(O-S4-3) Bueno J.L., Berzal L., Alonso R., Sanchez I., Gonzalez C.I., Salas A., Álamo J.R., Cruz J.L., Garcia A., Fernandez R., Bravo P., Cabrera J.R. (Spain)

(11:45 – 12:00) Introducing a Cloud-Based Hemovigilance System for Data Collection and Analysis: Lessons Learned from the Hemovigilance Program in Ghana
(O-S4-4) Rajbhandary S., Bales C., Whitaker B., Knox P, M., Cardoso M., Wilkinson S., Masaki M., Nealis S., Owusu-Oforie S., de Coning D.P., Ansah J.K., Asamoah-Akuoko L. (USA)

13:00 – 14:00 Plenary Lecture
Room: Quays Theatre
Chairpersons:  Whitaker B. (USA) and Bolton-Maggs, P. (United Kingdom)

Genomics and Big Data
(INV-14) Ouwehand W. (United Kingdom)

14:00 – 15:00 Plenary Session: Human Factors
Room: 
Quays Theatre
Chairpersons: Whitaker B. (USA) and Bolton-Maggs, P. (United Kingdom)

(14:00 – 14:30) What could possibly go wrong?
(INV-15) Bolton-Maggs P. (United Kingdom)

(14:30 – 15:00) Human Factors initiatives in haemovigilance: Preliminary experience from Serious Hazards of Transfusion (SHOT).
(INV-16) Watt A. (United Kingdom)

15:00 – 16:00 Awards and Closing Session
(15:00 – 15:15) Presentation of IHN Medals and Award
(15:15 – 15:45) Award winner lecture
(15:45 – 16:00) Closing words by the President of the IHN

THURSDAY, JULY 12, 2018

There is an opportunity for delegates to attend the Annual SHOT Symposium 2018 which will be held on Thursday, July 12 at the same venue, the Lowry Theatre.
For further programme information and for independent registration, please visit their website.